Item

Symptoms

Title (Dublin Core)

Symptoms

Disclaimer (Dublin Core)

DISCLAIMER: This item may have been submitted in response to a school assignment prompt. See Linked Data.

Description (Dublin Core)

Personally I don't know anyone that has gotten Covid 19 and I would prefer not to start now. I have heard however that the symptoms in everyone are different depending on your blood type, if you have asthma, diabetes, or any other immune disorder. The symptoms in a healthy person is just like an extended common cold. There is coughing, fatigue, light headedness, and fever. But, once it hits people who have asthma that could be a problem considering that Covid 19 attacks the lungs. It could damage their lungs even more which could potentially lead to death. Other than that the symptoms are pretty much the same. The thing that makes this particular virus dangerous is that no one shows symptoms for at least 2 weeks. So before you know its there, there is already a couple billion little virus cells in your body making you sick or worse. This disease mainly affects the elderly and is hard to control. it spreads quickly because it is an airborne disease. Some other symptoms are nausea and diarrhea. By now it is very well known about by now mostly because an insane 3.12 million people have died around the world because of it.

Date (Dublin Core)

Creator (Dublin Core)

Contributor (Dublin Core)

Partner (Dublin Core)

Type (Dublin Core)

text Story

Controlled Vocabulary (Dublin Core)

Curator's Tags (Omeka Classic)

Collection (Dublin Core)

Linked Data (Dublin Core)

Date Submitted (Dublin Core)

01/22/2021

Date Modified (Dublin Core)

02/18/2021

Date Created (Dublin Core)

01/22/2021

Item sets

This item was submitted on January 22, 2021 by Ian Matthies using the form “Share Your Story” on the site “A Journal of the Plague Year”: http://mail.covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA